Literature DB >> 8258751

Response of hypertension to conventional antihypertensive treatment and/or steroidogenesis inhibitors in Cushing's syndrome.

F Fallo1, A Paoletta, F Tona, M Boscaro, N Sonino.   

Abstract

OBJECTIVES: To evaluate the effect of conventional antihypertensive drugs and/or inhibitors of steroid production in the management of hypertension in Cushing's syndrome.
DESIGN: A retrospective open clinical study with pre- and post-treatment assessment.
SETTING: A university hospital, where patients were initially admitted and then followed-up in an ambulatory clinic over a period of 6 years.
SUBJECTS: Forty consecutive hypertensive patients with Cushing's syndrome.
INTERVENTIONS: Patients were divided into two groups according to the different management of hypertension. The first group (group 1) of 28 patients included those treated with antihypertensive drugs at full dose (diuretics, calcium antagonists, angiotensin converting enzyme [ACE] inhibitors, as single agents or in combination). The second group (group 2) of 12 patients received ketoconazole alone. MAIN OUTCOME MEASURES: Blood pressure variations compared to pre-treatment levels.
RESULTS: Blood pressure normalization was obtained in four of the 28 patients of group 1. In 12 of the remaining patients, ketoconazole, an inhibitor of steroid production, was subsequently added and this normalized blood pressure in all but the one in whom cortisol was not decreased. In the 12 patients of group 2, ketoconazole alone lowered blood pressure within normal limits in all but one who had long-standing hypertension.
CONCLUSIONS: In hypertensive patients with Cushing's syndrome, conventional antihypertensive therapy is mostly ineffective. Blood pressure response is satisfactory only after the restoration of normal cortisol levels, indicating the need for a specific treatment for hypertension in this disorder.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258751     DOI: 10.1111/j.1365-2796.1993.tb01018.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  12 in total

1.  Cushing's syndrome: all variants, detection, and treatment.

Authors:  Susmeeta T Sharma; Lynnette K Nieman
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

Review 2.  Glucocorticoid excess and hypertension.

Authors:  Smita Baid; Lynnette K Nieman
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

3.  A case of severe hypertension caused by ACTH-independent macronodular adrenal hyperplasia.

Authors:  R Nocente; Marinis L De; A Mancini; A Bianchi; R Bellantone; L Lauriola; M Costanzo; Crea C De; G Gasbarrini; Silveri N Gentiloni
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

Review 4.  Hypercortisolism in obesity-associated hypertension.

Authors:  Amy G Varughese; Oksana Nimkevych; Gabriel I Uwaifo
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

5.  Treatment of Cushing disease: overview and recent findings.

Authors:  Tatiana Mancini; Teresa Porcelli; Andrea Giustina
Journal:  Ther Clin Risk Manag       Date:  2010-10-21       Impact factor: 2.423

Review 6.  Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.

Authors:  Johannes M M Boots; Maarten H L Christiaans; Johannes P van Hooff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Cardiovascular autonomic function in Cushing's syndrome.

Authors:  F Fallo; P Maffei; A Dalla Pozza; M Carli; P Della Mea; M Lupia; F Rabbia; N Sonino
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

8.  Coronary microvascular function in patients with Cushing's syndrome.

Authors:  Francesco Fallo; Giulia Famoso; Dario Capizzi; Nicoletta Sonino; Francesca Dassie; Pietro Maffei; Chiara Martini; Agostino Paoletta; Sabino Iliceto; Francesco Tona
Journal:  Endocrine       Date:  2012-08-01       Impact factor: 3.633

Review 9.  The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.

Authors:  Andrea M Isidori; Chiara Graziadio; Rosa Maria Paragliola; Alessia Cozzolino; Alberto G Ambrogio; Annamaria Colao; Salvatore M Corsello; Rosario Pivonello
Journal:  J Hypertens       Date:  2015-01       Impact factor: 4.844

Review 10.  Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis.

Authors:  Leonie H A Broersen; Meghna Jha; Nienke R Biermasz; Alberto M Pereira; Olaf M Dekkers
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.